BORGHETTI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 3.892
AS - Asia 1.934
EU - Europa 1.829
SA - Sud America 319
AF - Africa 53
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 8.043
Nazione #
US - Stati Uniti d'America 3.822
SG - Singapore 678
CN - Cina 567
IT - Italia 546
DE - Germania 269
BR - Brasile 258
HK - Hong Kong 195
UA - Ucraina 180
PL - Polonia 152
VN - Vietnam 145
FI - Finlandia 136
FR - Francia 120
BD - Bangladesh 102
GB - Regno Unito 100
RU - Federazione Russa 77
TR - Turchia 76
NL - Olanda 58
IN - India 55
IE - Irlanda 54
CA - Canada 38
CZ - Repubblica Ceca 27
MX - Messico 22
AR - Argentina 21
ID - Indonesia 19
ZA - Sudafrica 19
ES - Italia 17
SE - Svezia 17
JP - Giappone 16
CO - Colombia 12
PK - Pakistan 12
IQ - Iraq 11
LT - Lituania 11
AT - Austria 9
EC - Ecuador 9
BE - Belgio 8
EG - Egitto 8
MA - Marocco 8
AU - Australia 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
EU - Europa 6
VE - Venezuela 6
BY - Bielorussia 5
GR - Grecia 5
IL - Israele 5
PH - Filippine 5
UZ - Uzbekistan 5
BO - Bolivia 4
HU - Ungheria 4
MK - Macedonia 4
MY - Malesia 4
TN - Tunisia 4
UG - Uganda 4
DK - Danimarca 3
NP - Nepal 3
PE - Perù 3
PT - Portogallo 3
RS - Serbia 3
TH - Thailandia 3
AM - Armenia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CL - Cile 2
CR - Costa Rica 2
ET - Etiopia 2
IR - Iran 2
IS - Islanda 2
JO - Giordania 2
KG - Kirghizistan 2
KR - Corea 2
KZ - Kazakistan 2
NG - Nigeria 2
PY - Paraguay 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AO - Angola 1
BB - Barbados 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
FJ - Figi 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
NR - Nauru 1
Totale 8.036
Città #
Ashburn 497
Singapore 383
Fairfield 315
San Jose 205
Chandler 198
Hong Kong 193
Woodbridge 180
Houston 178
Seattle 166
Warsaw 144
New York 140
Jacksonville 138
Cambridge 126
Beijing 119
Wilmington 114
Los Angeles 106
Helsinki 103
Dearborn 93
The Dalles 89
Munich 87
Princeton 84
Dallas 75
Ann Arbor 63
Istanbul 54
Brescia 52
Milan 52
Dublin 51
Lauterbourg 51
Ho Chi Minh City 50
Des Moines 39
Nanjing 39
Shanghai 35
São Paulo 30
Council Bluffs 28
Moscow 26
Santa Clara 26
Buffalo 24
Dong Ket 24
San Diego 24
Redondo Beach 23
San Francisco 23
Denver 22
London 22
Washington 22
Turku 20
Chennai 19
Hanoi 19
Orem 19
Boardman 18
Chicago 18
Brooklyn 17
Atlanta 16
Brno 16
Changsha 16
Nanchang 15
Rome 15
Tokyo 15
Johannesburg 13
Montreal 13
Frankfurt am Main 12
Jakarta 12
Poplar 12
Shenyang 12
Hebei 11
Paris 11
Jinan 10
Zhengzhou 10
Kunming 9
Tianjin 9
Toronto 9
Amsterdam 8
Ankara 8
Charlotte 8
Düsseldorf 8
Florence 8
Guangzhou 8
Mexico City 8
Nuremberg 8
Rio de Janeiro 8
Romola 8
Turin 8
Boston 7
Brasília 7
Brussels 7
Da Nang 7
Manchester 7
Naples 7
Phoenix 7
Stockholm 7
Bari 6
Bergamo 6
Bologna 6
Cairo 6
Campinas 6
Haiphong 6
Lancaster 6
Sydney 6
Tirana 6
Augusta 5
Cleveland 5
Totale 5.087
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 478
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 269
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 227
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 222
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 220
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 210
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 208
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 192
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 188
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 177
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 176
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 175
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 171
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 170
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 169
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 166
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 165
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 163
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 163
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 162
From Molecular to Clinical Radiation Biology of Glioblastoma 159
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 156
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 147
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 147
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 142
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 140
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 140
Current radiotherapy techniques in NSCLC: challenges and potential solutions 135
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 133
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 133
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 125
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort 122
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative study 118
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 116
The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy 112
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 111
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 110
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment 109
'Le Roi est mort, vive le Roi': New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With Immunotherapy 102
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 102
Prevention and management of acute esophageal toxicity during concomitant chemoradiotherapy for locally advanced lung cancer 102
The “Radioresistance” of Glioblastoma in the Clinical Setting, and the Present Therapeutic Options 101
Oligometastatic Mesothelioma Treated with Ablative Radiotherapy (OMAR): A Multicenter Study 99
Health-related quality of life 24-month after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 99
Letter to the Editor 91
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspective 88
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 84
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 83
Artificial Intelligence-suggested Predictive Model of Survival in Patients Treated With Stereotactic Radiotherapy for Early Lung Cancer 83
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group 81
Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia 80
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience 79
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 75
The role of postoperative radiotherapy for thymomas: a multicentric retrospective evaluation from three Italian centers and review of the literature 75
Unmet needs in the management of unresectable stage III non-small cell lung cancer: a review after the 'radio talk' webinars 67
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group 56
Ambient air pollution and survival in SCLC/LCNEC: Analysis of a single centre retrospective cohort 52
What Have You Been Told? Awareness of Prognosis of Patients in an Italian Home Palliative Care Service 51
Stereotactic body radiotherapy for spinal oligometastases: a survey on patterns of practice on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO) 47
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach 41
null 13
Totale 8.177
Categoria #
all - tutte 38.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 0 0 62
2021/2022437 35 38 10 13 27 31 26 34 27 47 24 125
2022/2023514 55 18 24 36 51 105 5 69 96 6 31 18
2023/2024775 29 16 94 45 45 179 35 47 102 41 36 106
2024/20251.337 28 40 26 195 100 139 89 73 147 119 234 147
2025/20262.898 265 284 196 398 330 217 380 90 216 245 165 112
Totale 8.177